As of today, Gilead Sciences, Inc. last 12-month Revenue is $27.8 bn , EBITDA is $12.2 bn and Net Income is $1.1 bn , based on the financial report for June 30, 2024 (Q2 2024).
As of today, Gilead Sciences, Inc. Total Assets are $53.6 bn and Total Liabilities are $35.4 bn , based on the financial report for June 30, 2024 (Q2 2024).
As of today, Gilead Sciences, Inc. last 12-month Cash Flow from Operating Activities is $1.3 bn, Cash Flow from Investing Activities is $-0.3 bn and Cash Flow from Financing Activities is $-3 bn, based on the financial report for June 30, 2024 (Q2 2024).
As of today, Gilead Sciences, Inc. last 12-month Free Cash Flow is $6.9 bn , based on the financial report for June 30, 2024 (Q2 2024).